BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31699964)

  • 1. FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia.
    Young MM; Bui V; Chen C; Wang HG
    Cell Death Dis; 2019 Nov; 10(11):847. PubMed ID: 31699964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
    Chen L; Luo LF; Lu J; Li L; Liu YF; Wang J; Liu H; Song H; Jiang H; Chen SJ; Luo C; Li KK
    PLoS One; 2014; 9(7):e103033. PubMed ID: 25050888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.
    Wallington-Beddoe CT; Hewson J; Bradstock KF; Bendall LJ
    Autophagy; 2011 Jul; 7(7):707-15. PubMed ID: 21460633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways.
    Baer A; Colon-Moran W; Bhattarai N
    Sci Rep; 2018 Jul; 8(1):10910. PubMed ID: 30026610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
    Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R
    J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.
    Estella-Hermoso de Mendoza A; Castello-Cros R; Imbuluzqueta E; Cirauqui C; Pippa R; Odero MD; Blanco-Prieto MJ
    J Biomed Nanotechnol; 2015 Apr; 11(4):691-701. PubMed ID: 26310075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid externalization of 27-kDa heat shock protein (HSP27) and atypical cell death in neutrophils treated with the sphingolipid analog drug FTY720.
    Skrzeczyńska-Moncznik J; Bzowska M; Nogieć A; Sroka A; Zarębski M; Vallières L; Guzik K
    J Leukoc Biol; 2015 Oct; 98(4):591-9. PubMed ID: 26216939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
    Vicente C; Arriazu E; Martínez-Balsalobre E; Peris I; Marcotegui N; García-Ramírez P; Pippa R; Rabal O; Oyarzábal J; Guruceaga E; Prósper F; Mateos MC; Cayuela ML; Odero MD
    Cancer Lett; 2020 Jan; 468():1-13. PubMed ID: 31593801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism.
    Bai LY; Chiu CF; Chiu SJ; Chu PC; Weng JR
    Sci Rep; 2017 Jul; 7(1):5600. PubMed ID: 28717222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.
    Zhang N; Qi Y; Wadham C; Wang L; Warren A; Di W; Xia P
    Autophagy; 2010 Nov; 6(8):1157-67. PubMed ID: 20935520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Immunomodulatory Drug Fingolimod (FTY720) on
    Zhou Z; Xie L; Wang L; Xue M; Xu D; Zhong G
    Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32868341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
    Zhang L; Wang H; Ding K; Xu J
    Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
    Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE
    J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 induces ferroptosis and autophagy via PP2A/AMPK pathway in multiple myeloma cells.
    Zhong Y; Tian F; Ma H; Wang H; Yang W; Liu Z; Liao A
    Life Sci; 2020 Nov; 260():118077. PubMed ID: 32810509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
    Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM
    Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate receptor modulation attenuate mechanical allodynia in mouse model of chronic complex regional pain syndrome by suppressing pathogenic astrocyte activation.
    Lee BJ; Kim JY; Cho HJ; Park D
    Reg Anesth Pain Med; 2020 Mar; 45(3):230-238. PubMed ID: 31969447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells.
    Woo SM; Seo BR; Min KJ; Kwon TK
    Oncotarget; 2015 May; 6(13):11614-26. PubMed ID: 25843953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation.
    McCracken AN; McMonigle RJ; Tessier J; Fransson R; Perryman MS; Chen B; Keebaugh A; Selwan E; Barr SA; Kim SM; Roy SG; Liu G; Fallegger D; Sernissi L; Brandt C; Moitessier N; Snider AJ; Clare S; Müschen M; Huwiler A; Kleinman MT; Hanessian S; Edinger AL
    Leukemia; 2017 Mar; 31(3):669-677. PubMed ID: 27573555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.